Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aeglea BioTherapeutics, Inc. (AGLE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| Alspaugh Jonathan (President and CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 19,787,969 options to buy
@ $0.3, valued at
$5.9M
|
|
| 06/30/2023 |
4
| Cox Russell J. (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 06/30/2023 |
4
| Magovcevic-Liebisch Ivana (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 06/30/2023 |
4
| Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 06/30/2023 |
4
| Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 1,950,000 options to buy
@ $0.3, valued at
$585k
|
|
| 02/24/2023 |
4
| Neuman Linda L (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 550,000 options to buy
@ $0.44, valued at
$242k
|
|
| 02/24/2023 |
4
| Kastenmayer James Paul (General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.44, valued at
$220k
|
|
| 02/24/2023 |
4
| Hanley Jr. Michael Conick (Chief Business Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $0.44, valued at
$220k
|
|
| 02/24/2023 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 640,000 options to buy
@ $0.44, valued at
$281.6k
|
|
| 01/27/2023 |
4
| Neuman Linda L (Chief Medical Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.36, valued at
$34k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2022 |
4
| Kastenmayer James Paul (Interim CEO & General Counsel) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 08/25/2022 |
4
| Souza Marcio (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 90,000 shares
@ $0.5608, valued at
$50.5k
|
|
| 08/25/2022 |
4
| Sloan Leslie (COO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 08/25/2022 |
4
| Hanley Jr. Michael Conick (Chief Business Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 08/25/2022 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 130,000 options to buy
@ $0.68, valued at
$88.4k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Souza Marcio (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 43,000 options to buy
@ $0.73, valued at
$31.4k
|
|
| 06/09/2022 |
4
| Smith Hunter C (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 43,000 options to buy
@ $0.73, valued at
$31.4k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 80,079 shares
@ $2.344, valued at
$187.7k
|
|
| 03/15/2022 |
4
| Quinn Anthony G. (President & CEO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 34,777 shares
@ $2.064, valued at
$71.8k
Bought 67,472 shares
@ $1.93, valued at
$130.2k
Bought 42,417 shares
@ $1.8611, valued at
$78.9k
|
|
| 03/15/2022 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 75,000 shares
@ $2.08, valued at
$156k
|
|
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Weber Steven (VP, Controller&Princ Acctg Off) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.17, valued at
$95.1k
|
|
| 02/22/2022 |
4
| Sloan Leslie (COO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $3.17, valued at
$570.6k
|
|
| 02/22/2022 |
4
| Hanley Jr. Michael Conick (Chief Commercial Officer) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 160,000 options to buy
@ $3.17, valued at
$507.2k
|
|
| 02/22/2022 |
4
| Alspaugh Jonathan (CFO) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $3.17, valued at
$538.9k
|
|
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|